teduglutide, GLP-2 受体激动剂

级别和纯度:

Moligand™

有货

关闭

关闭

货号 (SKU)	包装规格	是否现货	价格	数量
rp175268-500μg	500μg	期货
rp175268-1mg	1mg	期货

查看相关系列

GLP-2 receptor Agonist (9) 脂质代谢 (4331)

基本描述

产品名称	teduglutide, GLP-2 受体激动剂
别名	替度鲁肽
英文别名	s9935 \| revefenacinum \| HOVEYDA-GRUBBS CATALYST M72 \| GLP2-2G \| (Gly2)GLP-2 \| teduglutidum \| [Gly2]GLP-2 \| Teduglutide-d8 (Phe-d8) \| HSDB 8337 \| revestive \| DTXSID30471901 \| Teduglutide [USAN:INN:BAN] \| ALX 0600 \| Teduglutide \| ALX-0600 \| Gly(2)-GLP-2 \| G
规格或纯度	Moligand™
作用类型	激动剂
作用机制	GLP-2 受体激动剂

GLP2R Tclin 胰高血糖素类肽2受体(Glucagon-like peptide 2 receptor) (0 活性数据)

点击查看靶蛋白信息： GLP2R

活性类型	活性值-log(M)	作用机制	期刊	参考文献(PubMed IDs)

CAS编号和信息	197922-42-2

C of A & Other Certificates(BSE/TSE, COO):

输入批号以搜索分析图谱:

1. Yazbeck R. (2010) Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.. Curr Opin Mol Ther, 12 (6): (798-809). [PMID:21154171]
2. Jeppesen PB. (2012) Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.. Therap Adv Gastroenterol, 5 (3): (159-71). [PMID:22570676]
3. Blonski W, Buchner AM, Aberra F, Lichtenstein G. (2013) Teduglutide in Crohn's disease.. Expert Opin Biol Ther, 13 (8): (1207-14). [PMID:23834252]
4. Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H. (2017) Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.. J Clin Gastroenterol, 51 (6): (508-511). [PMID:27433811]